Indeed, the immunomodulation of tumor-infiltrating lymphocytes was observed after treatment, with an increase in CD45+, B, CD8+ T and highly cytolytic NK cells, although an increase in T regulatory cells was also detected [148]. Here, CD8A is linked to neoplasm.